Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine Mindmed Inc (NQ: MNMD )

8.920 -0.110 (-1.22%)
Streaming Delayed Price Updated: 11:25 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine Mindmed Inc

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public
Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021. Compass Pa... 
Via Benzinga
Exposures Product Safety
EXCLUSIVE: MindMed CEO Talks Mission To 'Discover, Develop And Deploy' Psychedelics
Mind Medicine Inc (NASDAQ: MNMD) was started to address mental wellness, CEO and co-founder J.R. Rahn told Benzinga's Global Small Cap Conference Thursday. MindMed... 
Via Benzinga
Benzinga Global Small Cap Conference: How Do Investors Pick Winners In The Psychedelics Space?
Simeon Schnapper, a managing partner at JLS Fund, took 30 minutes from his busy schedule to share his insights into what makes a w... 
Via Benzinga
Video: Psychedelic Stocks With JLS Fund's Simeon Schnapper & MindMed's JR Rahn
During the Benzinga Global Small-Cap Conference on Thursday morning, psychedelics executives discussed the markets and companies' prospects. 
Via Benzinga
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to the Cannabis Countdo... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psychedelics Stock MindMed Debuts On Nasdaq
Mind Medicine Inc. (NASDAQ:MNMD) commenced trading it... 
Via Benzinga
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound... 
Via Benzinga
Video: The Psychedelics Market With Entheon Biomedical, MagicMed, Natan Ponieman
Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday’s show, hosts Patrick&... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Smaller Psychedelics Companies Should Start Catching Up To The Sector Leaders
Concentration of ownership in psychedelic drug stocks has reached a new extreme. We explain how and why we don't see this trend as being sustainable. 
Via Talk Markets
The Next Psychedelic Stock To Uplist On The Nasdaq?
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next? 
Via Talk Markets
When Will The Selling Pressure In These 2 Hot Stocks End?
On April 29, shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) hit a wall of resistance at the $4.30 level. Since then, they have been in a freefall. There’s a good... 
Via Benzinga
Mind Medicine Stock Is Soaring After Its NASDAQ Debut. What's Next?
Diversification may be a prudent step. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Precipio (NASDAQ:PRPO) stock moved upwards by 111.42% to $3.85 during Monday's regular session. The current volume of 113.0 million shares is 18552.84% of... 
Via Benzinga
Is It Time to Sell These 3 Stocks?
It may be time to sell GameStop Corp. (NYSE: GME), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), and Archer-Daniels-Midland Company (NYSE: ADM) and the reasons why will... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers BioVie (NASDAQ:BIVI) shares increased by 12.96% to $19.78 during Monday's pre-market session. The company's market cap stands at $275.2 million. Ocugen (... 
Via Benzinga
Fintech Focus Roundup For May 2, 2021
Apex Fintech Solutions Announces Blow-Out Earnings Ahead Of NYSE Listing What Happened: Blank-check company Northern Star Investment Corporation II announced that Apex... 
Via Benzinga
Exposures Glyphosate
The 'Boiler Room' Stock Pitch Recap: MindMed, Ford, Generac, Microchip And More
Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO ... 
Via Benzinga
MindMed Stock Hits A Wall Of Resistance
Shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) have hit a wall of resistance at the $4.30 level. This has put a top on the stock. Resistance is a large concentration of... 
Via Benzinga
MindMed's Nasdaq Listing Enables Institutions Diversified Access To A New Age Of Medicine
Mind Medicine (MindMed) Inc (NASDAQ:MNMD) (NEO: MMED), a l... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Clover Health Investments (NASDAQ:CLOV) shares moved upwards by 16.01% to $10.72 during Wednesday's regular session. The current volume of 64.6 million shares... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of... 
Via Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per... 
Via Benzinga
Why Companies Are Betting Big On Psychedelic Drugs To Treat Mental Health Epidemic
Via FinancialNewsMedia
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7... 
Via Benzinga
25 Stocks Moving in Wednesday's Pre-Market Session
Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today.... 
Via Benzinga
MNMD Stock: A MindMed Buzz Kill as the Psychedelic Shares Tank on First Day of Trading
MindMed (MNMD) stock isn't doing so hot with shares taking a beating on the first day of trading at their new home on the Nasdaq. 
Via InvestorPlace
MindMed Stock Climbs In Nasdaq Debut As Psychedelics Follow Pot's Path To Mainstream
MindMed stock rose in its Nasdaq listing debut on Tuesday, making it the latest psychedelic drug developer to land on a major U.S. exchange. 
Via Investor's Business Daily
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.